Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Nov 19, 2022 1:33am
630 Views
Post# 35112255

Profitability

ProfitabilityThanks for the response Navajo and Biorun.

Here's the thing about profitability:

Hopeful Howhee and crafty Chris have consistently used words in the press releases that we might have come to trust, were it not for the smooth connotation put on them to make it sound like we are going places.  Anybody that knows about financials surely realize that we can't be profitable if the execs continue to create huge unwarranted wage, bonus and salary expenses, so tell me how we are going to become profitable under these circumstances?  They have always created huge payrolls long before we got any real revenue, so back to accounting 101. Sirona, show us a 'BUDGET' for 2023 for a change and maybe we can believe some of it.

They take as much money as the conscience allows and then still add on 10% for good measure.  This is absolutely not controlling expenses.

We demand that you prepare a budget for 2023 seeings that you are bold enough to announce that we should soon be profitable.  The proof is in the fugures.  I don't think we as shareholders should any longer put up with these illusions.

What do some of you other shareholders think about this?

BeAlert, and don't forget to look back over your investment shoulders.

<< Previous
Bullboard Posts
Next >>